Ustekinumab Treats Psoriasis by Suppressing RORC and T-Box But Its Suppression of GATA Restrains Its Efficacy. Braz. J. Pharm. Sci. 2018, 54 (4), e17349. https://doi.org/10.1590/s2175-97902018000417349.